You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Prenetics:會繼續留意早期癌症檢測及英國診所等併購機會
阿思達克 12-19 12:21
Prenetics(PRE.US)將收購行動基因多數股權,預付代價包括1,990萬股Prenetics普通股及2,000萬美元現金,預計行動基因將於明年貢獻2,500萬至3,000萬美元的收入,料收購將於今年12月30日前後完成。 Prenetics行政總裁兼聯合創始人楊聖武指,公司一直留意更多併購機會,發展大方向包括研發及留意遠距醫療技術,公司亦對癌症復康及護理、早期檢測等感興趣,亦有關注英國一些傳統及成熟的診所。 行動基因執行長陳華健表示,次世代基因定序(NGS)檢測在台灣市佔75%,在本港亦具有領導地位,希望之後能繼續提升市場份額。行動基因主席莫樹錦期望,公司可繼續發展東南亞市場,以至在全球佔一席之位。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account